By Scott Murdoch HONG KONG (Reuters) – China’s Giant Biogene Holding Co Ltd launched on Tuesday an initial public offering (IPO) in Hong Kong to raise up to $80 million, a term sheet showed, sharply lower than its original target of $500 million amid a major
